Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Ketosis: early-phase trial registry

3 of 5 indexed Ketosis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Ketosis: 5 US clinical trials tracked, 3 recruiting.

Ketosis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Ohio State University, running 2 of these trials.

Enrollment posture brief

Registry condition ketosis

OPEN 3 | RECR 60% | LATE 0 | EARLY 2 | RANK #3391 | SPON 2

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Ketosis (this)60%
Open-enrollment share among volume-matched conditions near Ketosis

Ketosis lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Ketosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Ketosis is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Ketosis research.

    Ohio State University accounts for 2 of 5 trials (40%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Most Ketosis trials plan to enrol fewer than 100 people.

    Median target enrolment is 30 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Ketosis research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22

Phase Distribution

PhaseTrial count
Phase 2 2

Top Sponsors

Named interventions

Most-linked intervention names on Ketosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Blood Draw Biological
2 trials
Beverage Tolerability Questionnaire (BTQ) and satiety visual analogue scale Behavioral
2 trials
Ketone Supplement Dietary supplement
2 trials
LEVL (Medamonitor) Device
1 trials
Heart Rate Variability Other
1 trials
Breath Reading Other
1 trials
Alcohol beverage Other
1 trials
Kenetik Dietary supplement
1 trials

US sites by state

Facility locations filed on Ketosis trials. A trial with sites in several states counts in each.

Pennsylvania 2 trials
Ohio 2 trials
Washington 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Ketosis page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ketosis condition card totals 5 registered trials; most-linked intervention Blood Draw; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.